Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla

Saved in:
Bibliographic Details
Main Authors: Amy N Courtney, Gengwen Tian, Leonid S Metelitsa, Andras Heczey
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/3/e011858.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849389388851576832
author Amy N Courtney
Gengwen Tian
Leonid S Metelitsa
Andras Heczey
author_facet Amy N Courtney
Gengwen Tian
Leonid S Metelitsa
Andras Heczey
author_sort Amy N Courtney
collection DOAJ
format Article
id doaj-art-7c8d756b2bd64f15acab25c9d8093193
institution Kabale University
issn 2051-1426
language English
publishDate 2025-03-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-7c8d756b2bd64f15acab25c9d80931932025-08-20T03:41:58ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-03-0113310.1136/jitc-2025-011858Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and AtillaAmy N Courtney0Gengwen Tian1Leonid S Metelitsa2Andras Heczey3Center for Advanced Innate Cell Therapy, Texas Children`s Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USACenter for Advanced Innate Cell Therapy, Texas Children`s Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USACenter for Advanced Innate Cell Therapy, Texas Children`s Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USACenter for Advanced Innate Cell Therapy, Texas Children`s Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USAhttps://jitc.bmj.com/content/13/3/e011858.full
spellingShingle Amy N Courtney
Gengwen Tian
Leonid S Metelitsa
Andras Heczey
Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
Journal for ImmunoTherapy of Cancer
title Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
title_full Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
title_fullStr Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
title_full_unstemmed Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
title_short Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla
title_sort response to correspondence on hyperleukocytosis in a neuroblastoma patient after treatment with natural killer t cells expressing a gd2 specific chimeric antigen receptor and il 15 by ataca atilla and atilla
url https://jitc.bmj.com/content/13/3/e011858.full
work_keys_str_mv AT amyncourtney responsetocorrespondenceonhyperleukocytosisinaneuroblastomapatientaftertreatmentwithnaturalkillertcellsexpressingagd2specificchimericantigenreceptorandil15byatacaatillaandatilla
AT gengwentian responsetocorrespondenceonhyperleukocytosisinaneuroblastomapatientaftertreatmentwithnaturalkillertcellsexpressingagd2specificchimericantigenreceptorandil15byatacaatillaandatilla
AT leonidsmetelitsa responsetocorrespondenceonhyperleukocytosisinaneuroblastomapatientaftertreatmentwithnaturalkillertcellsexpressingagd2specificchimericantigenreceptorandil15byatacaatillaandatilla
AT andrasheczey responsetocorrespondenceonhyperleukocytosisinaneuroblastomapatientaftertreatmentwithnaturalkillertcellsexpressingagd2specificchimericantigenreceptorandil15byatacaatillaandatilla